CAMP4 Therapeutics Corporation
CAMP | NASDAQ
$4.06
-$0.11 (-2.64%)
Sep 22, 2026, 12:48 PM ET · Market open
Company Profile
CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and development of new therapeutic solutions for patients.
Key Executives
| Name | Position |
|---|---|
| Joshua Mandel-Brehm | Chief Executive Officer, President & Director |
| Kelly Gold | Chief Financial Officer |
| Michelle Gates | Senior Vice President & Chief People Officer |
| Alla Sigova | Senior Vice President of Platform |
| Caleb Moore | Chief Business Operations Officer |
| Daniel Tardiff | Chief Scientific Officer |
| Leonard I. Zon | Founder & Chairman of Scientific Advisory Board |
| Richard A. Young | Founder & Independent Director |
| Satya Kuchimanchi | Senior Vice President of Technical Operations |
| Yuri Maricich | Chief Medical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 02, 2026 | 4 | Filing |
| Aug 31, 2026 | SC 13D/A | [Amend] Filing |
| Aug 31, 2026 | 4 | Filing |
| Aug 26, 2026 | 4 | Filing |
| Aug 21, 2026 | 4 | Filing |
| Aug 19, 2026 | 4 | Filing |
| Aug 19, 2026 | SC 13D/A | [Amend] Filing |
| Aug 14, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 13, 2026 | 10-Q | Quarterly Report |
| Aug 13, 2026 | 8-K | Current Report |
CAMP4 Therapeutics Corporation
| Country | United States |
| IPO Date | Oct 10, 2024 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 48 |
| CEO | Joshua Mandel-Brehm |
Contact Details
One Kendall Square Bldg 1400 West, 3rd Floor Cambridge,
Massachusetts 02139 United States
Stock Details
| Ticker Symbol | CAMP |
| Exchange | NASDAQ |
| Fiscal Year | March - February |
| Reporting Currency | USD |
| CIK Code | 0001736730 |
| CUSIP Number | 13463J101 |
| ISIN Number | US13463J1016 |
| SIC Code | 3663 |
Add to Watchlist
Select watchlists to add or remove CAMP